卡西迪提案拟封堵药企关注的海关漏洞
A bill introduced in the Senate aims to close a customs “loophole” that the pharma industry has had on its radar as a potential way to mitigate tariffs.
The measure, by ...
⚠️ 风险分析 中
摘要：美国参议院提案拟封堵药企利用的海关漏洞，可能增加关税成本。
影响：若法案通过，依赖该漏洞规避关税的医药企业（包括在美有业务的中国药企）将面临更高的进口成本和合规风险。
建议：评估现有供应链的关税策略，准备应对潜在的海关合规变化，并寻求替代方案。
「素履以往」
Not the sharpest mind, but the steadiest hand.
Not the sharpest mind, but the steadiest hand.